Assigned to the Institute for Drug Control of the Ministry of Health (now China Institute for Drug and Biological Products Control), transferred from 65438 to 0985, and transferred to the Drug Evaluation Office of the Ministry of Health (now the Drug Evaluation Center of the State Pharmaceutical Products Administration). He has served as director, director and researcher, and is also a member of the National Expert Committee on New Drug Research and Development, the Expert Committee of the Medical Science and Technology Consulting and Development Department of the Chinese Pharmaceutical Association, the member of the Beijing Drug Evaluation Committee, and the editorial board member of the Journal of Foreign Medicine and Pharmacy. Specializing in pharmacology and toxicology.
Engaged in drug verification and research before the Cultural Revolution. In the 1970s, he undertook the tasks of medication and health care of the central leaders. Since 1980s, he has been mainly engaged in the research, development and evaluation of new drugs.
The main articles are the experimental design study of insulin determination in rabbits, pharmacological study of musk, comparison between Tibetan and Yunnan Notoginseng, therapeutic effect and toxicity of Edexin on animal tumors, titer determination of tetrandrine injection, OECD guidelines for toxicity test of chemical substances (translated), application requirements of new drug approval procedures and technical data, and related issues of new drug research and development. Enjoy the special government allowance of the State Council.
Refer to the above? Zhu Yan (researcher, Drug Evaluation Center, State Administration of Pharmaceutical Products) _ Baidu Encyclopedia